TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing ...
TORONTO--Cybin Inc. (Cboe CA: CYBN) (NYSE American: CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback